Amy Rick joins FDA’s newly formed Rare Disease Innovation Hub

FDA named Amy Rick director of strategic coalitions for the newly established Rare Disease Innovation Hub, which will serve as a point of contact for the rare disease community and coordinate research. Rick was a principal consultant at Leavitt Partners and president and CEO of Food and Drug Law Institute. 

Cardiovascular metabolic disease company Anthos Therapeutics Inc. named Will Kane president and chief commercial officer, and Venkat Ramanan CFO. Kane was CCO at Karuna Therapeutics Inc. and Ramanan was CFO of Turnstone Biologics Corp. (NASDAQ:TSBX)...